Orion Oyj

Pharmaceuticals
ORNBV.HE
€ 38 1.8
Share price
$ 5.6 bn
Market Cap
$ 5.5 bn
Enterprise Value

Carbon footprint

3.8 Ton
GHG emissions per $ 1 mln investment
0.13x the weighted average for S&P 500
FY2021
How is this calculated?
+11%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-12%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Stronger than the -5.1% weighted average for S&P 500
FY2022
How is this calculated?

Orion Oyj aims to reduce Scope 1 + 2 by 75% by 2025 from a base year 2016


This target has not been verified as science based according to SBTi
Orion Oyj's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Orion Oyj's GHG emissions (market-based) (Kt of CO2e)
Orion Oyj's Carbon intensity (Tons per 1 USDm)

Orion Oyj's carbon footprint

Orion Oyj reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 21 Kt (+2/+10% y-o-y). Carbon intensity also was up at 17 t (+1.9/+13% y-o-y).

Orion Oyj reported Scope 3 emissions for the the twelve months ending31 December 2021 at 554

The company is committed to reducing Scope 1 + 2 by 75% by 2025 from a base year 2016, which translates into the estimated reduction of -2.4 Kt per annum over the period of FY2022 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...